In order to demonstrate the possibility that amurensin H exerted its anti-COPD inflammation function might be due to the inhibition of Syk/NF-κB pathway, Syk inhibitor (BAY61-3606) and NF-κB inhibitor (BAY11-7082) were chosen. Here, SYK is linked to chronic obstructive pulmonary disease.